Microbiological analysis and predictors of gallbladder infection with antimicrobial susceptibility patterns in an HIV setting
DOI:
https://doi.org/10.7196/SAMJ.2023.v113i6.442Keywords:
HIV, laparoscopic cholecystectomy, bile microbiology, bacteriobilia, antimicrobial resistance, empirical antimicrobial therapy, antibiograms, CRP, PCT, NLRAbstract
Background
South Africa has a high prevalence of people living with human immunodeficiency virus (HIV; PLWH) who have shown to affect the prevalence and severity of infection and sepsis particularly gallbladder disease. Empirical Antimicrobial (EA) therapy for acute cholecystitis (AC) is based largely on bacteria colonisation of bile (bacteriobilia) and antimicrobial susceptibility patterns (antibiograms) obtained from the developed world where the prevalence of PLWH is very low. In an ever-emerging era of increasing antimicrobial resistance, monitoring and updating local antibiograms is underscored.
Objective
Due to the paucity of data available locally to guide treatment we found it pertinent to examine gallbladder bile for bacteriobilia and antibiograms in a setting with a high prevalence of PLWH to determine if this may demand a review of our local antimicrobial policies for gallbladder infections for both EA and pre-operative antimicrobial prophylaxis (PAP) for laparoscopic cholecystectomies (LC).
Methodology
A retrospective observational descriptive study was undertaken at King Edward VIII Hospital, Durban, KwaZulu-Natal, South Africa. Hospital records were reviewed for all patients undergoing cholecystectomy over a 3-year period. Gallbladder bacteriobilia and antibiograms were assessed and compared between PLWH and HIV uninfected (HIV-U). Pre-operative age, ERCP, PCT, CRP and NLR were used as predictors for bacteriobilia. Statistical analyses were performed using R Project and p values of less than 0.05 were considered as statistically significant.
Results
There were no differences in bacteriobilia or antibiograms between PLWH and HIV-U. There was >30% resistance to amoxicillin/clavulanate and cephalosporins. Aminoglycoside-based therapy, had good susceptibility patterns whilst carbapenem-based therapy demonstrated the lowest resistance levels. ERCP and age were predictors of bacteriobilia (p<0.001 and 0.002 respectively). PCT, CRP and NLR were not.
Conclusion
PLWH should follow the same PAP and EA recommendations as HIV-U. For EA, we recommend, a combination of amoxicillin/clavulanate with aminoglycoside-based therapy (amikacin or gentamycin) or piperacillin/tazobactam as monotherapy. Carbapenem-based therapy should be reserved for drug resistant species. For PAP, we recommend the routine use in older patients and patients with history of ERCP undergoing LC.
References
Stinton LM, Myers RP, Shaffer EA. Epidemiology of gallstones. Gastroenterol Clin North Am 2010;39(2):157-169. https://doi.org/10.1016/j.gtc.2010.02.003
KhanZA,KhanMU,BrandM.IncreasesincholecystectomyforgallstonerelateddiseaseinSouthAfrica. Sci Rep 2020;10(1):13516. https://doi.org/10.1038/s41598-020-69812-3
Myer PA, Mannalithara A, Singh G, Singh G, Pasricha PJ, Ladabaum U. Clinical and economic burden of emergency department visits due to gastrointestinal diseases in the United States. Am J Gastroenterol 2013;108(9):1496-1507. https://doi.org/10.1038/ajg.2013.199
Elkeles G, Mirizzi PL. A study of the bacteriology of the common bile duct in comparison with the other extrahepatic segments of the biliary tract. Ann Surg 1942;116(3):360-366. https://doi. org/10.1097/00000658-194209000-00007
De Oliveira RS, da Silva P, Queiroz CAS, Terra-Júnior JA, Crema E. Prevalence of bacteriobilia in patients undergoing elective colecystectomy. Arq Bras Cir Dig 2018;31(3):e1392. https://doi.org/10.1590/0102- 672020180001e1392
Mayumi T, Okamoto K, Takada T, et al. Tokyo Guidelines 2018: Management bundles for acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci 2018;25(1):96-100. https://doi.org/10.1002/jhbp.519
Mbatha SZ, Anderson F. Outcomes in laparoscopic cholecystectomy in a resource constrained environment. S Afr J Surg 2016;54(3):8-12.
Makatini GM, Mewa Kinoo S, Singh B. An audit of interval cholecystectomy for acute cholecystitis in a low resource healthcare system. S Afr J Surg 2020;58(1):10-13.
Gomi H, Solomkin JS, Takada T, et al. TG13 antimicrobial therapy for acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci 2013;20(1):60-70. https://doi.org/10.1007/s00534-012-0572-0
Kinoo SM, Nagiah S, Chuturgoon A, Singh B. Symptomatic gallstones and HIV in black South African women: Changing trends of gallstone disease? South Afr J HIV Med 2021;22(1):1208. https://doi. org/10.4102/sajhivmed.v22i1.1208
Nash JA, Cohen SA. Gallbladder and biliary tract disease in AIDS. Gastroenterol Clin North Am 1997;26(2):323-335. https://doi.org/10.1016/s0889-8553(05)70297-1
HusonMAM,GrobuschMP,vanderPollT.TheeffectofHIVinfectiononthehostresponsetobacterial sepsis. Lancet Infect Dis 2015;15(1):95-108. https://doi.org/10.1016/S1473-3099(14)70917-X
Liang B, Dai M, Zou Z. Safety and efficacy of antibiotic prophylaxis in patients undergoing elective laparoscopic cholecystectomy: A systematic review and meta‐analysis. J Gastroenterol Hepatol 2016;31(5):921-928. https://doi.org/10.1111/jgh.13246
Gomi H, Solomkin JS, Schlossberg D, et al. Tokyo Guidelines 2018: Antimicrobial therapy for acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci 2018;25(1):3-16. https://doi.org/10.1002/ jhbp.518
MazuskiJE,TessierJM,MayAK,etal.TheSurgicalInfectionSocietyrevisedguidelinesonthemanagement of intra-abdominal infection. Surg Infect (Larchmt) 2017;18(1):1-76. https://doi.org/10.1089/sur.2016.261
Sung YK, Lee JK, Lee KH, Lee KT, Kang C-I. The clinical epidemiology and outcomes of bacteremic biliary tract infections caused by antimicrobial-resistant pathogens. J Am Gastroenterol 2012;107(3):473-
https://doi.org/10.1038/ajg.2011.387
KwonW,JangJ-Y,KimE-C,etal.Changingtrendinbilemicrobiologyandantibioticsusceptibilities:Over
years of experience. Infection 2013;41(1):93-102. https://doi.org/10.1007/s15010-012-0358-y
Coccolini F, Sartelli M, Catena F, et al. Antibiotic resistance pattern and clinical outcomes in acute cholecystitis: 567 consecutive worldwide patients in a prospective cohort study. Int J Surg 2015;21:32-37.
https://doi.org/10.1016/j.ijsu.2015.07.013
JordanoQ,FalcóV,AlmiranteB,etal.InvasivepneumococcaldiseaseinpatientsinfectedwithHIV:Still a threat in the era of highly active antiretroviral therapy. Clin Infect Dis 2004;38(11):1623-1628. https:// doi.org/10.1086/420933
Chiliza KS, Madela F, Tlou B, Anderson F. Obstructive jaundice: Studies on predictors of biliary infection and microbiological analysis in an HIV setting. S Afr Med J 2021;111(8):803-808. https://doi. org/10.7196/SAMJ.2021.v111i8.15255
ParekhPM,ShahNJ,SutharPP,etal.Bacteriologicalanalysisofbileincholecystectomypatients.IntJRes Med Sci 2017;3(11):3091-3096. https://doi.org/10.18203/2320-6012.ijrms20151142
Yun SP, Seo H-I. Clinical aspects of bile culture in patients undergoing laparoscopic cholecystectomy. Medicine (Baltimore) 2018;97(26):e11234. https://doi.org/10.1097/MD.0000000000011234
Solomkin JS, Mazuski JE, Bradley JS, et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: Guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Surg Infect (Larchmt) 2010;11(1):79-109. https://doi.org/10.1089/sur.2009.9930
AnsaloniL,PisanoM,CoccoliniF,etal.2016WSESguidelinesonacutecalculouscholecystitis.WorldJ Emerg Surg 2016;11:25. https://doi.org/10.1186/s13017-016-0082-5
Shafagh S, Rohani SH, Hajian A. Biliary infection: Distribution of species and antibiogram study. Ann Med Surg (Lond) 2021;70:102822. https://doi.org/10.1016/j.amsu.2021.102822
Vohra RS, Hodson J, Pasquali S, Griffiths EA. Effectiveness of antibiotic prophylaxis in non-emergency cholecystectomy using data from a population-based cohort study. World J Surg 2017;41(9):2231-2239. https://doi.org/10.1007/s00268-017-4018-3
Sarkut P, Kilicturgay S, Aktas H, Ozen Y, Kaya E. Routine use of prophylactic antibiotics during laparoscopic cholecystectomy does not reduce the risk of surgical site infections. Surg Infect (Larchmt) 2017;18(5):603-609. https://doi.org/10.1089/sur.2016.265
Takada T, Strasberg SM, Solomkin JS, et al. TG13: Updated Tokyo Guidelines for the management of acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci 2013;20(1):1-7. https://doi.org/10.1007/ s00534-012-0566-y
Jaafar G, Sandblom G, Lundell L, Hammarqvist F. Antibiotic prophylaxis in acute cholecystectomy revisited: Results of a double-blind randomised controlled trial. Langenbecks Arch Surg 2020;405(8):1201- 1207. https://doi.org/10.1007/s00423-020-01977-x
Bratzler DW, Dellinger EP, Olsen KM, et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Surg Infect (Larchmt) 2013;14(1):73-156. https://doi.org/10.1089/sur.2013.9999
Darkahi B, Sandblom G, Liljeholm H, Videhult P, Melhus Å, Rasmussen IC. Biliary microflora in patients undergoing cholecystectomy. Surg Infect (Larchmt) 2014;15(3):262-265. https://doi.org/10.1089/ sur.2012.125
Stahl EC, Brown BN. Cell therapy strategies to combat immunosenescence. Organogenesis 2015;11(4):159-172. https://doi.org/10.1080/15476278.2015.1120046
Yasuda H, Takada T, Kawarada Y, et al. Unusual cases of acute cholecystitis and cholangitis: Tokyo Guidelines. J Hepatobiliary Pancreat Surg 2007;14(1):98-113. https://doi.org/10.1007/s00534-006-1162-9 34. Asai K, Watanabe M, Kusachi S, et al. Bacteriological analysis of bile in acute cholecystitis according to the Tokyo Guidelines. J Hepatobiliary Pancreat Sci 2012;19(4):476-486. https://doi.org/10.1007/s00534-
-0463-9
Rupp C, Bode K, Weiss KH, et al. Microbiological assessment of bile and corresponding antibiotic treatment: A strobe-compliant observational study of 1401 endoscopic retrograde cholangiographies. Medicine (Baltimore) 2016;95(10):e2390. https://doi.org/10.1097/MD.0000000000002390
Granel-Villach L, Gil-Fortuno M, Fortea-Sanchis C, Gamon-Giner RL, Martinez-Ramos D, Escrig-Sos VJ. Factors that influence bile fluid microbiology in cholecystectomised patients. Rev Gastroenterol Mex 2020;85(3):257-263. https://doi.org/10.1016/j.rgmx.2019.07.006
Steccanella F, Amoretti P, Barbieri MR, Bellomo F, Puzziello A. Antibiotic prophylaxis for hepato- biliopancreatic surgery – a systematic review. Antibiotics (Basel) 2022;11(2):194. https://doi.org/10.3390/ antibiotics11020194
RegimbeauJM,FuksD,PautratK,etal.Effectofpostoperativeantibioticadministrationonpostoperative infection following cholecystectomy for acute calculous cholecystitis: A randomized clinical trial. JAMA 2014;312(2):145-154. https://doi.org/10.1001/jama.2014.7586
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Roxanne Singh, Suman Mewa Kinoo, Praksha Ramjathan, Khine Swe Swe-Han, Bhugwan Singh
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Licensing Information
The SAMJ is published under an Attribution-Non Commercial International Creative Commons Attribution (CC-BY-NC 4.0) License. Under this license, authors agree to make articles available to users, without permission or fees, for any lawful, non-commercial purpose. Users may read, copy, or re-use published content as long as the author and original place of publication are properly cited.
Exceptions to this license model is allowed for UKRI and research funded by organisations requiring that research be published open-access without embargo, under a CC-BY licence. As per the journals archiving policy, authors are permitted to self-archive the author-accepted manuscript (AAM) in a repository.
Publishing Rights
Authors grant the Publisher the exclusive right to publish, display, reproduce and/or distribute the Work in print and electronic format and in any medium known or hereafter developed, including for commercial use. The Author also agrees that the Publisher may retain in print or electronic format more than one copy of the Work for the purpose of preservation, security and back-up.
